Overtesting

Call to improve transparent communication in direct-to-consumer test marketing – Emma Grundtvig Gram et al.

2024-08-06T11:23:30+10:00HPV, Imaging, Low-value care, Overdiagnosis, Overtesting, Overuse, Publications, Screening, Tests, Too much|

All tests ‘(…) do harm; some do good as well, and, of these, some do more good than harm at reasonable cost.’ - Muir Gray and Angela Raffle. Medical tests are widely and increasingly marketed directly to consumers via traditional and social media. Such tests may [...]

Women’s interest, knowledge, and attitudes relating to anti-Mullerian hormone testing: a randomized controlled trial – T Copp et al.

2024-08-06T10:31:59+10:00Overtesting, Overuse, Publications, Tests, Women's health|

The anti-Mullerian hormone (AMH) can be measured by a blood test and gives an indication of the number of oocytes in the ovaries, but not of oocyte quality . Whilst the test is helpful in assisted reproduction as it roughly indicates the potential number of [...]

Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review – Kristen Pickles et al.

2024-06-05T13:40:38+10:00Carbon footprint, Carbon neutral, Climate change, Health system, Low-value care, Overtesting, Publications, Sustainable health care|

The delivery of modern healthcare is inadvertently exacerbating illness and injury to populations through its own pollution. The global healthcare sector—health services and its medical supply chain—is responsible for approximately 5% of global net greenhouse gas (GHG) emissions (>2 gigatons of carbon dioxide equivalent (CO2e)) [...]

Less is more for greener intensive care – Katy J. L. Bell & Rachel Stancliffe

2024-06-05T13:31:10+10:00Carbon footprint, Carbon neutral, Climate change, End of life, Low-value care, Overdiagnosis, Overtesting, Publications, Sustainable health care|

Climate change threatens human health and increases demand for healthcare. Global temperature is rising in near linear relationship with increasing carbon dioxide (CO2) in Earth’s atmosphere, bringing hotter and more extreme weather. Health consequences include direct injuries, deaths and illness, and indirect effects such as [...]

Health benefits and harms of mammography screening in older women (75+ years)—a systematic review – Erin Mathieu et al.

2024-04-07T15:40:26+10:00Ageing, Breast cancer, Cancer, Overdiagnosis, Overtesting, Publications, Screening, Women's health|

There is little evidence on the balance between potential benefits and harms of mammography screening in women 75 years and older. The aim of this systematic review was to synthesise the evidence on the outcomes of mammography screening in women aged 75 years and older.

Evidence for overdiagnosis in noncancer conditions was assessed: a metaepidemiological study using the ‘Fair Umpire’ framework – Sharon Sanders et al.

2024-04-07T15:30:38+10:00Overdiagnosis, Overtesting, Overuse, Publications, Research, Tests|

To our knowledge, this is the first methodological review of studies concerned with overdiagnosis in noncancer conditions. We identified 132 studies identifying or quantifying overdiagnosis of a wide range of noncancer conditions. We applied a novel framework that uses the concept of ‘‘Fair Umpires’’ to [...]

ABC News – Feminism ‘co-opted’ to market non-evidence-based women’s health interventions like AMH ‘egg timer’ tests, researchers argue

2024-02-19T12:42:18+11:00News, Overdiagnosis, Overtesting, Overtreatment, Women's health|

At 38, Carla Loughnane was told she had so few eggs she was near menopause and didn't need birth control. Within six months, she was pregnant. Her twin girls were not yet two years old. This "miracle" baby was a joy, but made her doubt years [...]

The Conversation – Feminist narratives are being hijacked to market medical tests not backed by evidence

2024-02-19T11:14:08+11:00News, Overdiagnosis, Overtesting, Overtreatment, Women's health|

Corporations have used feminist language to promote their products for decades. In the 1980s, companies co-opted messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol. Today, feminist narratives around empowerment and women’s rights are being co-opted to market interventions [...]

Marketing empowerment: how corporations co-opt feminist narratives to promote non-evidence based health interventions – Copp et al.

2024-02-16T10:55:01+11:00Overdiagnosis, Overtesting, Overtreatment, Publications, Women's health|

Promotion of non-evidence based tests and treatments using empowerment messages risks women being overdiagnosed and overtreated, argue Tessa Copp and colleagues. Commercial organisations have an extraordinary influence on population health through how they engage with and shape social movements to market their products.1 Corporations have historically exploited [...]

Go to Top